Sign in to follow
Search Results

0 results for 'Bristol-Myers Squibb Pharmaceuticals'

You can use to get even better search results
November 03, 2022 | New Jersey Law Journal

$763 Per Pill: Lawsuit Accuses Drugmakers of Scheme Involving Cancer Medicine Revlimid

"Defendants' settlement agreement constitutes a horizontal output-restriction and market-allocation agreement—a per se violation of the Sherman Act," the suit says.
3 minute read
October 18, 2022 | New Jersey Law Journal

Bristol-Myers Squibb Taps Morgan Lewis in Employee Class Action Over COVID-19 Vaccination Policy

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
October 03, 2022 | New Jersey Law Journal

Bristol-Myers Squibb Facing Suit From Workers Fired for Refusing COVID Vaccine

"According to Bristol-Myers Squibb, people who worked on their computers all day remotely during the pandemic couldn't be accommodated. They didn't try," plaintiffs lawyer John Coyle said.
4 minute read
September 29, 2022 | Corporate Counsel

'Don't Leave the Junky Work to Somebody Else': A Veteran Legal Chief Shares Leadership Lessons

"I believe firmly in training each person in the legal department to take over from me—to be my successor," said Stephen Kim, chief legal officer of Avicanna.
8 minute read
September 28, 2022 | New York Law Journal

'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket

The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case that originated in the Southern District of New York. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.
12 minute read
Law Journal Press | Digital Book State Antitrust Law Authors: William T. Lifland View this Book

View more book results for the query "Bristol-Myers Squibb Pharmaceuticals"

September 27, 2022 | National Law Journal

'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket

The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.
12 minute read
August 30, 2022 | New Jersey Law Journal

Bristol-Myers Squibb Facing Suit Over Termination Based on Vaccine Status

This suit was surfaced by Law.com Radar. Read the document here.
1 minute read
August 12, 2022 | Litigation Daily

Litigators of the Week: Walden Macht & Haran Team Hits Eli Lilly With Whistleblower Verdict

The $61 million verdict that Dan Miller, Jonathan DeSantis and Derek Cohen landed in Chicago federal court last week stands to be trebled to more than $183 million under the False Claims Act.
8 minute read
August 05, 2022 | Litigation Daily

Another Stacked Week of Litigator of the Week Runners-Up and Shout Outs

Runners-up include lawyers from Kirkland & Ellis, Sidley Austin, White & Case and Baker Botts who got a major win to stand up in one of the first antitrust cases involving biologic drugs.
6 minute read
July 25, 2022 | Corporate Counsel

Veteran Pharma Lawyer Takes Strategy Role at Drug-Naming Powerhouse

After a combined 33 years at Bristol-Myers Squibb and Amgen, Timothy Gaul is joining a consultancy that helped name three-quarters of the drugs approved worldwide last year.
1 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now